174 related articles for article (PubMed ID: 14632753)
1. Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.
Goodier MR; Imami N; Moyle G; Gazzard B; Gotch F
Clin Exp Immunol; 2003 Dec; 134(3):470-6. PubMed ID: 14632753
[TBL] [Abstract][Full Text] [Related]
2. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
[TBL] [Abstract][Full Text] [Related]
3. The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.
Dillon SM; Lee EJ; Bramante JM; Barker E; Wilson CC
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):259-67. PubMed ID: 24091697
[TBL] [Abstract][Full Text] [Related]
4. NK cells of HIV-1-infected patients with poor CD4
Giuliani E; Vassena L; Di Cesare S; Malagnino V; Desimio MG; Andreoni M; Barnaba V; Doria M
Immunol Lett; 2017 Oct; 190():185-193. PubMed ID: 28826739
[TBL] [Abstract][Full Text] [Related]
5. Cytokine activation induces human memory-like NK cells.
Romee R; Schneider SE; Leong JW; Chase JM; Keppel CR; Sullivan RP; Cooper MA; Fehniger TA
Blood; 2012 Dec; 120(24):4751-60. PubMed ID: 22983442
[TBL] [Abstract][Full Text] [Related]
6. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
[TBL] [Abstract][Full Text] [Related]
7. 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.
Ostrowski SR; Ullum H; Pedersen BK; Gerstoft J; Katzenstein TL
Clin Exp Immunol; 2005 Sep; 141(3):526-33. PubMed ID: 16045743
[TBL] [Abstract][Full Text] [Related]
8. Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects.
Vitale M; Caruso A; Licenziati S; Rodella L; Fiorentini S; Zauli G; Castelli F; Manzoli FA; Turano A
Cytometry; 2000 Mar; 39(3):189-94. PubMed ID: 10685075
[TBL] [Abstract][Full Text] [Related]
9. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.
Azzoni L; Papasavvas E; Chehimi J; Kostman JR; Mounzer K; Ondercin J; Perussia B; Montaner LJ
J Immunol; 2002 Jun; 168(11):5764-70. PubMed ID: 12023377
[TBL] [Abstract][Full Text] [Related]
10. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
11. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
Mantegani P; Tambussi G; Galli L; Din CT; Lazzarin A; Fortis C
Immunology; 2010 Feb; 129(2):220-33. PubMed ID: 19824914
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
13. CD56
Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
[TBL] [Abstract][Full Text] [Related]
14. Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort.
Nabatanzi R; Bayigga L; Cose S; Rowland-Jones S; Canderan G; Joloba M; Nakanjako D
Clin Immunol; 2019 Apr; 201():55-60. PubMed ID: 30817998
[TBL] [Abstract][Full Text] [Related]
15. IL-21 augments natural killer effector functions in chronically HIV-infected individuals.
Strbo N; de Armas L; Liu H; Kolber MA; Lichtenheld M; Pahwa S
AIDS; 2008 Aug; 22(13):1551-60. PubMed ID: 18670213
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
[TBL] [Abstract][Full Text] [Related]
17. Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients.
Jacobs R; Weber K; Wendt K; Heiken H; Schmidt RE
J Clin Immunol; 2004 May; 24(3):281-6. PubMed ID: 15114058
[TBL] [Abstract][Full Text] [Related]
18. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection.
Vasan S; Poles MA; Horowitz A; Siladji EE; Markowitz M; Tsuji M
Int Immunol; 2007 Aug; 19(8):943-51. PubMed ID: 17702988
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
20. Immune function and phenotype before and after highly active antiretroviral therapy.
Søndergaard SR; Aladdin H; Ullum H; Gerstoft J; Skinhøj P; Pedersen BK
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):376-83. PubMed ID: 10458618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
